“Successful Management of Steroid-Resistant cutaneous Acute Graft-versus-Host Disease, Toxic Epidermal Necrolysis-Like, with Ruxolitinib” (2025) Mediterranean Journal of Hematology and Infectious Diseases, 17(1), p. e2025020. doi:10.4084/MJHID.2025.020.